Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FTLUU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,541
Award facts
- Contract value 100% obligated
- $19,540.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,540.52 for Otezla 30 mg tablets (60-count) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp fulfills delivery orders through the DLA's medical supply chain to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Otezla (apremilast) is an oral immunomodulatory medication primarily used to treat plaque psoriasis and psoriatic arthritis, representing the type of specialty pharmaceutical products routinely procured through the company's IDC vehicle. This delivery order exemplifies AmerisourceBergen's ongoing role as a primary pharmaceutical supplier within the federal medical procurement framework.
Quick answers
Who was awarded contract SPE2DB26FTLUU?
SPE2DB26FTLUU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FTLUU worth?
The government has obligated $19,541 on SPE2DB26FTLUU.
Is contract SPE2DB26FTLUU an order under another contract?
Yes. SPE2DB26FTLUU is a delivery order under SPE2DB25D7056, an indefinite delivery contract.
Was contract SPE2DB26FTLUU competed?
The extent of competition for SPE2DB26FTLUU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award